CoChat

Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

Rodriguez‐Perdigon, Manuel, Tordera, Rosa María, Gil‐Bea, Francisco Javier, Gerenu, Gorka, Ramirez, Maria Javier, Solas, Maite · 2016 · Hippocampus
Cited by 47

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is characterized phenotypically by memory impairment, histologically by accumulation of pTau and β‐amyloid peptide and morphologically by a loss of nerve terminals in cortical and hippocampal regions. As glutamate is the principle excitatory neurotransmitter of the central nervous system (CNS), the glutamatergic system may play an important role in AD. To date, not many studies have addressed the deleterious effects of Aβ on glutamatergic terminals; therefore the aim of this study was to investigate how Aβ affects glutamatergic terminals and to assess the extent to which alterations in the glutamatergic neurotransmission could impact susceptibility to the illness. The present study shows that Aβ caused a loss of glutamatergic terminals, measured by VGLUT1 protein levels, in Tg2576 primary cell cultures, Tg2576 mice and AD patient brains, and also when Aβ was added exogenously to hippocampal cell cultures. Interestingly, no correlation was found between cognition and decreased VGLUT1 levels. Moreover, when Aβ 1–42 was intracerebroventricularlly administered into VGLUT1+/‐ mice, altered synaptic plasticity and increased neuroinflammation was observed in the hippocampus of those animals. In conclusion, the present study not only revealed susceptibility of glutamatergic nerve terminals to Aβ induced toxicity but also underlined the importance of VGLUT1 in the progression of AD, as the decrease of this protein levels could increase the susceptibility to subsequent deleterious inputs by exacerbating Aβ induced neuroinflammation and synaptic plasticity disruption. © 2016 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hipo.22607

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 35

  1. 10.1523/JNEUROSCI.1856-09.2009 · DOI
  2. 10.1016/j.ejphar.2006.06.045 · DOI
  3. 10.1523/JNEUROSCI.3269-07.2007 · DOI
  4. 10.1126/science.289.5481.957 · DOI · Paper page
  5. 10.1523/JNEUROSCI.3728-09.2009 · DOI · Paper page
  6. 10.1016/j.neuropharm.2013.08.026 · DOI
  7. 10.1016/j.neurobiolaging.2011.09.021 · DOI
  8. 10.1016/S0301-0082(00)00067-8 · DOI · Paper page
  9. 10.1016/j.neuron.2007.09.001 · DOI · Paper page
  10. 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  11. 10.1016/j.biopsych.2009.02.027 · DOI
  12. 10.1126/science.1072994 · DOI · Paper page
  13. 10.1111/j.1471-4159.2006.04144.x · DOI
  14. 10.1126/science.274.5284.99 · DOI · Paper page
  15. 10.1016/j.neuron.2006.10.035 · DOI · Paper page
  16. 10.3233/JAD-2003-5106 · DOI
  17. 10.1016/j.neurobiolaging.2007.04.010 · DOI · Paper page
  18. 10.1111/j.1471-4159.2006.03935.x · DOI · Paper page
  19. 10.1212/WNL.0b013e3181fd6328 · DOI
  20. 10.1212/WNL.57.5.805 · DOI · Paper page
  21. Lawlor PA, 2010, Animal Models of Dementia, 347
  22. 10.1016/S0893-133X(01)00393-1 · DOI · Paper page
  23. 10.1006/exnr.2000.7386 · DOI
  24. 10.1101/lm.69204 · DOI · Paper page
  25. 10.1111/j.1471-4159.2007.05147.x · DOI · Paper page
  26. 10.1038/cddis.2015.72 · DOI · Paper page
  27. 10.1016/S0896-6273(03)00434-3 · DOI · Paper page
  28. 10.3233/JAD-2010-100090 · DOI · Paper page
  29. 10.1016/j.bbadis.2016.01.004 · DOI
  30. 10.1016/j.nbd.2011.08.027 · DOI · Paper page
  31. 10.1016/S0022-510X(00)00285-9 · DOI · Paper page
  32. 10.1002/ana.410300410 · DOI · Paper page
  33. 10.3233/JAD-130437 · DOI
  34. 10.1111/j.1460-9568.2006.05259.x · DOI · Paper page
  35. 10.1523/JNEUROSCI.4391-04.2005 · DOI · Paper page

Cited by

See all 47

Metadata

Authors
Rodriguez‐Perdigon, M., Tordera, R. M., Gil‐Bea, F. J., Gerenu, G., Ramirez, M. J., & Solas, M.
Venue
Hippocampus
Publisher
Wiley
Published
2016-06-21
Volume
26
Issue
10
Pages
1303-1312
ISSN
  • 1050-9631 (ISSN-L)
  • 1098-1063
OpenAlex
W2414111041
Cited by
47
References
19
FWCI
2.74
Type
journal article
Language
en
Open access
closed
Funders
  • Instituto de Salud Carlos III (FIS 13/00858)
  • Federación Española de Enfermedades Raras

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease. https://app.cochat.ai/papers/10.1002/hipo.22607
The paper
Rodriguez‐Perdigon, M., Tordera, R. M., Gil‐Bea, F. J., Gerenu, G., Ramirez, M. J., & Solas, M. (2016). Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease. Hippocampus. https://doi.org/10.1002/hipo.22607

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.